Telotristat ethyl in carcinoid syndrome: Safety and efficacy in the TELECAST phase 3 trial

  1. Pavel, M.
  2. Gross, D.J.
  3. Benavent, M.
  4. Perros, P.
  5. Srirajaskanthan, R.
  6. Warner, R.R.P.
  7. Kulke, M.H.
  8. Anthony, L.B.
  9. Kunz, P.L.
  10. Hörsch, D.
  11. Weickert, M.O.
  12. Lapuerta, P.
  13. Jiang, W.
  14. Kassler-Taub, K.
  15. Wason, S.
  16. Fleming, R.
  17. Fleming, D.
  18. Garcia-Carbonero, R.
Aldizkaria:
Endocrine-Related Cancer

ISSN: 1479-6821,  1351-0088

Argitalpen urtea: 2018

Alea: 25

Zenbakia: 3

Orrialdeak: 309-322

Mota: Artikulua

DOI: 10.1530/ERC-17-0455 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus